Rankings
▼
Calendar
ORKA Q1 2024 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$19,000
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$168,000
Free Cash Flow
-$168,000
Stock-Based Comp.
$85,000
Balance Sheet
Total Assets
$37M
Total Liabilities
$2M
Stockholders' Equity
$35M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$19,000
-$29,000
+34.5%
Operating Income
-$2M
-$2M
-38.2%
Net Income
-$2M
-$1M
-49.3%
← FY 2024
All Quarters
Q2 2024 →